U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Approval Year

Name Type Language
\Immunoglobulin G1, anti-(human tyrosine kinase receptor ErbB2) (human-Mus musculus monoclonal RC48-270A4023 ?1-chain), disulfide with human-Mus musculus monoclonal RC48-270A4023 ?-chain, dimer, thioether with N-[[[4-[[N-[6-(3-mercapto-2,5-dioxo-1-pyrrol
Preferred Name English
Disitamab Vedotin
USAN   INN  
Official Name English
DISITAMAB VEDOTIN [USAN]
Common Name English
Immunoglobulin G1-kappa, anti-[Homo sapiens ERBB2 (epidermal growth factor receptor 2, receptor tyrosine-protein kinase erbB-2, EGFR2, HER2, HER-2, p185c-erbB2, NEU, CD340)], humanized monoclonal antibody conjugated to auristatin E; gamma1 heavy chain hu
Common Name English
RC48-ADC
Code English
Disitamab Vedotin [WHO-DD]
Common Name English
disitamab vedotin [INN]
Common Name English
Classification Tree Code System Code
FDA ORPHAN DRUG 649418
Created by admin on Wed Apr 02 00:59:50 GMT 2025 , Edited by admin on Wed Apr 02 00:59:50 GMT 2025
Code System Code Type Description
SMS_ID
300000005885
Created by admin on Wed Apr 02 00:59:50 GMT 2025 , Edited by admin on Wed Apr 02 00:59:50 GMT 2025
PRIMARY
USAN
MN-186
Created by admin on Wed Apr 02 00:59:50 GMT 2025 , Edited by admin on Wed Apr 02 00:59:50 GMT 2025
PRIMARY
CAS
2136633-23-1
Created by admin on Wed Apr 02 00:59:50 GMT 2025 , Edited by admin on Wed Apr 02 00:59:50 GMT 2025
PRIMARY
NCI_THESAURUS
C169918
Created by admin on Wed Apr 02 00:59:50 GMT 2025 , Edited by admin on Wed Apr 02 00:59:50 GMT 2025
PRIMARY
INN
10933
Created by admin on Wed Apr 02 00:59:50 GMT 2025 , Edited by admin on Wed Apr 02 00:59:50 GMT 2025
PRIMARY
FDA UNII
RB3U3A1S27
Created by admin on Wed Apr 02 00:59:50 GMT 2025 , Edited by admin on Wed Apr 02 00:59:50 GMT 2025
PRIMARY